JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DHIL
3726
DELISTED
Diamond Hill
DHIL
| $2.91M | ﹤0.01% |
18,731
+7,469
| +66% | +$1.2M |
2017 Q4
28 quarters
|
|
3727
TETRA Technologies
TTI
$888M
| $2.9M | ﹤0.01% |
810,581
+299,876
| +59% | +$1.07M |
2016 Q4
32 quarters
|
|
3728
Daily Journal
DJCO
$905M
| $2.9M | ﹤0.01% |
5,099
+2,133
| +72% | +$1.14M |
2017 Q4
28 quarters
|
|
3729
Beazer Homes USA
BZH
$891M
| $2.89M | ﹤0.01% |
105,306
+25,484
| +32% | +$814K |
2015 Q4
36 quarters
|
|
3730
CALL
Lam Research
LRCX
$435B
| $2.89M | ﹤0.01% |
40,000
| – | – |
2021 Q1
15 quarters
|
|
3731
Nuveen ESG Small-Cap ETF
NUSC
$1.25B
| $2.89M | ﹤0.01% |
68,885
-1,883
| -3% | -$82.2K |
2022 Q3
9 quarters
|
|
3732
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.33B
| $2.88M | ﹤0.01% |
120,396
+43,646
| +57% | +$1.03M |
2023 Q3
5 quarters
|
|
3733
PUT
Axsome Therapeutics
AXSM
$9.39B
| $2.88M | ﹤0.01% |
+34,000
| New | +$3.13M |
2024 Q4
0 quarters
|
|
3734
Castle Biosciences
CSTL
$1.09B
| $2.88M | ﹤0.01% |
107,936
+38,527
| +56% | +$1.17M |
2019 Q3
21 quarters
|
|
3735
CALL
Fastenal
FAST
$58.2B
| $2.88M | ﹤0.01% |
80,000
| – | – |
2024 Q1
3 quarters
|
|
|
3736
PUT
Fastenal
FAST
$58.2B
| $2.88M | ﹤0.01% |
80,000
| – | – |
2024 Q1
3 quarters
|
|
3737
Quanterix
QTRX
$172M
| $2.87M | ﹤0.01% |
270,054
+52,097
| +24% | +$634K |
2018 Q1
27 quarters
|
|
3738
Cerence
CRNC
$366M
| $2.87M | ﹤0.01% |
365,594
-25,949
| -7% | -$130K |
2019 Q4
20 quarters
|
|
3739
Dimensional Global Core Plus Fixed Income ETF
DFGP
$3.53B
| $2.87M | ﹤0.01% |
54,293
+2,491
| +5% | +$135K |
2024 Q2
2 quarters
|
|
3740
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.32B
| $2.87M | ﹤0.01% |
19,891
+80
| +0.4% | +$11.4K |
2022 Q2
10 quarters
|
|
|
FPI
3741
Farmland Partners
FPI
$490M
| $2.86M | ﹤0.01% |
243,045
+117,350
| +93% | +$1.38M |
2016 Q1
35 quarters
|
|
3742
Reynolds Consumer Products
REYN
$4.7B
| $2.86M | ﹤0.01% |
105,827
-93,160
| -47% | -$2.64M |
2020 Q2
18 quarters
|
|
3743
CALL
McKesson
MCK
$105B
| $2.85M | ﹤0.01% |
5,000
| – | – |
2024 Q2
2 quarters
|
|
3744
Columbus McKinnon
CMCO
$483M
| $2.85M | ﹤0.01% |
76,512
+49,498
| +183% | +$1.8M |
2013 Q2
46 quarters
|
|
3745
ADT
ADT
$4.57B
| $2.84M | ﹤0.01% |
410,814
-73,955
| -15% | -$539K |
2018 Q1
27 quarters
|
|
3746
Invesco Aerospace & Defense ETF
PPA
$7.41B
| $2.84M | ﹤0.01% |
24,741
+8,523
| +53% | +$1.01M |
2021 Q2
14 quarters
|
|
|
DHC
3747
Diversified Healthcare Trust
DHC
$1.87B
| $2.84M | ﹤0.01% |
1,233,790
+369,984
| +43% | +$1.09M |
2020 Q1
19 quarters
|
|
3748
PDF Solutions
PDFS
$2.34B
| $2.83M | ﹤0.01% |
104,627
+30,552
| +41% | +$921K |
2016 Q1
35 quarters
|
|
3749
UFP Technologies
UFPT
$2.33B
| $2.83M | ﹤0.01% |
11,573
+525
| +5% | +$153K |
2017 Q4
28 quarters
|
|
3750
Shinhan Financial Group
SHG
$36.6B
| $2.83M | ﹤0.01% |
85,999
+81,553
| +1,834% | +$3.15M |
2013 Q3
45 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.